🇺🇸 Boosted Protease Inhibitor in United States

Boosted Protease Inhibitor (Boosted Protease Inhibitor) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Boosted Protease Inhibitor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Boosted Protease Inhibitor approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Boosted Protease Inhibitor in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.